Biopalette

About:

Biopalette is a operator of a platform intended to offer gene-editing techniques.

Website: http://biopalette.co.jp

Top Investors: F-Prime Capital, ARCH Venture Partners, Eight Roads Ventures, JAFCO, Eight Roads Ventures Japan

Description:

Biopalette is a operator of a platform intended to offer gene-editing techniques. Bio Palette plans to develop our business in three fields, classified based on the type of cells targeted for genome editing.

Total Funding Amount:

$18.3M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Kobe, Kyoto, Japan

Founded Date:

2017-02-21

Founders:

Shinichi Fuki

Number of Employees:

11-50

Last Funding Date:

2020-09-24

IPO Status:

Private

Industries:

© 2025 bioDAO.ai